Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CHALLENGER LIMITED Director's Dealing 2019

Sep 15, 2019

64641_rns_2019-09-15_cd3cdaf3-f498-4799-a102-3398b65ba7d4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [102 x 21] intentionally omitted <==

Sydney

Level 2, 5 Martin Place Sydney NSW 2000 Australia GPO Box 3698 Sydney NSW 2001 www.challenger.com.au

Telephone 02 9994 7000 Facsimile 02 9994 7777

16 September 2019

Mr George Tharian Senior Adviser, Listings Compliance ASX Exchange Centre 20 Bridge Street Sydney, NSW 2000

Dear George,

Appendix 3Y – Change of Director’s Interest

Attached is an Appendix 3Y for Mr Richard Howes, Challenger’s Chief Executive Officer, for the award of Deferred Performance Rights (i.e. STI bonus) for the year ended 30 June 2019.

Yours sincerely,

==> picture [157 x 39] intentionally omitted <==

Andrew Brown Company Secretary

Melbourne Level 19, 31 Queen Street PO Box 297, Flinders Lane, Melbourne VIC 3000 Telephone 02 9994 7000 Facsimile 02 9994 7777 Brisbane Level 9, 241 Adelaide Street GPO Box 3234, Brisbane QLD 4001 Telephone 07 3136 5400 Facsimile 07 3136 5407 Perth Level 26, 140 St Georges Terrace, Perth WA 6000 Telephone 08 6466 9613 Adelaide Level 7, Suite 714, 147 Pirie Street, Adelaide SA 5000 Telephone 08 8427 9511

Challenger Limited ABN 85 106 842 371 Challenger Group Services Pty Limited ABN 91 085 657 307 Challenger Life Company Limited ABN 44 072 486 938 AFSL 234670 Challenger Investment Partners Limited ABN 29 092 382 842 AFSL 234 678 Challenger Retirement and Investment Services Limited ABN 80 115 534 453 AFSL295642 RSE Licence No. L0001304 Challenger Mortgage Management Pty Ltd ABN 72 087 271 109 Challenger Securitisation Management Pty Ltd ABN 56 100 346 898 AFSL 244593 Challenger Investment Solutions Management Pty Ltd ABN 63 130 035 353 AFSL 487354

==> picture [18 x 842] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

7Rule 3.19A.2

Appendix 3Y Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Challenger Limited
ABN 85 106 842 371

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Richard Howes
Date of last notice 9 September 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Investments in financial products issued by
related bodies corporate of Challenger Limited:

Guaranteed Annuity issued by Challenger
Life Company Limited for his spouse, Mrs
Melissa Howes.

$5,102,019.76
of
units
in
certain
registered managed investment schemes
issued
by
Fidante
Partners
Limited
(5,149,391 units) held by the Howes
Family Trust.
Date of change 9 September 2019
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change 561,478 ordinary shares
Investments in financial products issued by
related bodies corporate of Challenger Limited:

$2,500,000 of Guaranteed Annuities
issued by Challenger Life Company Limited
(including an annuity for his spouse, Mrs
Melissa Howes); and

$5,102,019.76 of units in certain
registered managed investment schemes
issued
by
Fidante
Partners
Limited
(5,149,391 units) held by the Howes Family
Trust.
Class Ordinary shares
Number acquired N/A
Number disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
N/A
No. of securities held after change 561,478 ordinary shares
Investments in financial products issued by
related
bodies
corporate
of
Challenger
Limited:

$2,500,000 of Guaranteed Annuities
issued by Challenger Life Company Limited
(including an annuity for his spouse, Mrs
Melissa Howes); and

$5,102,019.76 of units in certain
registered managed investment schemes
issued
by
Fidante
Partners
Limited
(5,149,391 units) held by the Howes Family
Trust.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
N/A

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Detail of contract As previously disclosed, Mr Howes held 780,251
Performance
Rights
under
the
Challenger
Performance Plan comprising:

101,381 Deferred Performance Rights; and

678,870 Hurdled Performance Rights.
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change Grant of 2019 Deferred Performance Rights on 9
September 2019.
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which
the interest has changed
N/A
Interest acquired 94,220 Deferred Performance Rights
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change 874,471 Performance Rights comprising:

195,601 Deferred Performance Rights; and

678,870 Hurdled Performance Rights.

Part 3 –[+] Closed period

Were the interests in the securities or
contracts detailed above traded during a
+closed
period
where
prior
written
clearance was required?
No
If so, was prior written clearance provided
to allow the trade to proceed during this
period?
N/A
If prior written clearance was provided, on
what date was this provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 3

01/01/2011